Medpace Holdings

MEDP · NASDAQ · USD

598,08 $Variación respecto al cierre anterior: −4,18 %Variación absoluta: −26,10 $

Cierre · 1 de octubre de 2026

Perfil de la empresa

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Descripción disponible en inglés.

Datos societarios

Sector
Salud
Industria
Diagnostics & Research
Sede
5375 Medpace Way, 45227, Cincinnati
Empleados
6.500
Cotización
MEDP · NASDAQ
Divisa
USD
Sitio web
medpace.com